Traders should monitor for downward pressure on DNTH shares, especially given the concentration of sales among top executives. Absent offsetting positive news, this level of insider selling may signal lack of confidence at the leadership level.
Price Chart
Executive Summary
Three Dianthus Therapeutics executives, including the CEO and EVP of R&D, exercised stock options and sold shares in the open market, collectively realizing over $7.5 million in proceeds. The sales represent a coordinated monetization of equity, with the CEO alone selling $3.5 million worth of stock.
Key Financial Metrics
Key Facts
- CEO Garcia Marino sold 43,505 shares for $3.51 million after exercising options totaling 122,918 shares.
- EVP Randhawa sold 33,830 shares for $2.76 million following option exercises.
- Chief Accounting Officer Carr sold 15,852 shares for $1.28 million.
- Total open-market sales by insiders: $7.53 million in one day.
- All transactions occurred on 2026-03-12, indicating a coordinated cluster.
Financial Impact
$7.53 million in insider sales, representing 0.21% of Dianthus's $3.6B market cap
Risk Factors
- Perception of insider pessimism ahead of key clinical or financing events
- Potential for follow-on selling or secondary offerings
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (9 trades, 7d window) | cluster-DNTH-1773448232345 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▲ +8.12% | ▲ +6.22% | $89.96 (+19.97%) |
Aug 10, 2026 7w ago | 144 | $108.49 $107.04 | ▼ −1.34% | ▼ −0.28% | $89.96 (−17.08%) |
Jun 29, 2026 13w ago | Press Release | $95.68 $103.87 | ▲ +8.56% | ▲ +8.84% | $89.96 (−5.98%) |
Jun 12, 2026 16w ago | 8-K | $82.07 $97.60 | ▲ +18.92% | ▲ +17.14% | $89.96 (+9.61%) |
Jun 11, 2026 16w ago | Institutional Cluster | $76.45 $100.03 | ▲ +30.84% | ▲ +28.95% | $89.96 (+17.67%) |
May 5, 2026 21w ago | 8-K | $90.42 $84.97 | ▼ −6.03% | ▼ −8.81% | $89.96 (−0.51%) |
Mar 12, 2026 29w ago | Press Release | $77.86 $90.00 | ▲ +15.59% | ▲ +12.00% | $89.96 (+15.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access